MedTech News
.................... by Andrew Celentano
ManaMed® Secures FDA 510(k) Clearance for PlasmaFlow® X — a Breakthrough, Compact Sequential Compression System with All-Day Battery
DENTON, Texas, Oct. 20, 2025 /PRNewswire/ — ManaMed today announced FDA 510(k) clearance for PlasmaFlow® X, the next-generation, tubeless sequential compression system that’s redefining recovery. Cleared as a Class II device, PlasmaFlow X is more compact, smarter, and longer-lasting—delivering powerful therapy in a sleek, portable package.
Glaukos picks up FDA approval for Epoxia incision-free keratoconus treatment
Glaukos (NYSE:GKOS) announced today that the FDA approved its Epoxia incision-free alternative to traditional corneal cross-linking procedures.
Rhythio wins FDA breakthrough nod for injectable electrode tech for defibrillation
Rhythio Medical announced today that it received FDA breakthrough device designation for its Injectable Electrode System.
In a surprising discovery, scientists find tiny loops in the genomes of dividing cells
Enabled by a new high-resolution mapping technique, the findings overturn a long-held belief that the genome loses its 3D structure when cells divide.
An LLM that can process and display transmitted cardiac data in real time
In addition to linguistic prompts, large language models can also understand, interpret, and adapt their responses to heart frequency data. Dr. Morris Gellisch, previously of Ruhr University Bochum, Germany, and now at University of Zurich, Switzerland, and Boris Burr from Ruhr University Bochum have developed a technical interface through which the physiological data can be transmitted to the language model in real time.
AI-powered method combines blood data to more accurately measure biological age
Researchers from Edith Cowan University (ECU) have developed an innovative new way to measure biological age, which could make it easier to detect and track age-related conditions.
Automated algorithm can detect cancer in blood samples in as little as 10 minutes
When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a means to detect the presence of cancer by detecting these cancer cells floating in blood samples. However, current state-of-the-art methods have necessitated trained specialists to comb through and review images of thousands of cells out of potentially millions of cells on a slide over a period of many hours.
Color Health, Google Cloud team up for breast cancer screening access
The initiative is set to continue until the end of 2025, with backing from Google.org.